Skip to Content
You are currently on the new version of our website. Access the old version .
Medical SciencesMedical Sciences
  • Review
  • Open Access

9 November 2018

12 Pages

Theranostics Applications of Nanoparticles in Cancer Immunotherapy

,
,
,
,
,
,
and
1
Department of Biomedical Engineering, School of Biomedical Engineering and Informatics, Nanjing Medical University, Nanjing 211166, China
2
State Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, China
3
Key Laboratory of Clinical Medical Engineering, Nanjing Medical University, Nanjing 211166, China
*
Author to whom correspondence should be addressed.

Abstract

With the advancement in the mechanism of immune surveillance and immune evasion in cancer cells, cancer immunotherapy shows promising results for treating cancer with established efficacy and less toxicity. As a result of the off-target effect, the approach for delivering vaccines, adjuvants, or antibodies directly to tumor sites is gaining widespread attention. An effective alternative is to utilize nanoengineered particles, functioning as drug-delivery systems or as antigens themselves. This article reviews the practical implementation of nanotechnology in cancer immunotherapy.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.